However, in a tumor-bearing mouse model, no obvious difference of tumor size shrinkage was observed under the therapy of anti-PD-1 combined with acetate or propionate compared with that of administration with a single dose of anti-PD-1 (Fig. S3e, f). Here, PDCD1 is linked to neoplasm.